$HCSG

Healthcare Services Group, Inc. Stock 12‑Month Price Target Cut to $26.67, Implies 26% Upside

Analysts cut Healthcare Services Group's 12-month price target from $27 to $26.67, with a range of $24 to $30. This implies 26% upside from the Oct. 6 closing price. The consensus rating remains 'Buy' among 7 analysts, with 4 Buys and 3 Holds.

Original reporting
Published Oct 7, 2026, 10:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 10:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Healthcare Services Group, Inc. Stock 12‑Month Price Target Cut to $26.67, Implies 26% Upside — source image
Decision brief

The 30-second read

$HCSGNeutralLow
01

Why it matters

The price‑target adjustment reflects a slight downgrade in growth expectations but retains a buy rating.

02

Market read

Analyst target change offers modest trading insight for HCSG; broader market impact is minimal.

03

What to watch

Recent contract wins or cost‑control measures could offset the target reduction.

Relevance 5/10Novelty 5/10Timing: pre‑market today

Background

Healthcare Services Group provides outpatient services and has been under analyst coverage for several quarters.

Company-level read

Ticker impact

$HCSGNeutralMedium confidence
Context

Analysts lowered the average price target for Healthcare Services Group to $26.67, implying about 26% upside from the current price.

Expected impact

likely slight pressure as the market prices in the lower target, but upside remains if price stays near current levels

Evidence & confidence

A modest target reduction is news but not a material catalyst; traders may adjust positions cautiously.

Market effects

Minor impact on the healthcare services sector as analysts adjust expectations.

Limited to U.S. small‑cap healthcare stocks.

Low

Counterpoint

Some investors may view the target cut as an overreaction and hold for potential upside.

Key entities

  • Healthcare Services Group, Inc.

    U.S. listed healthcare services provider (NASDAQ:HCSG).

Related articles

$HCSGMed

Healthcare Services Group Inc (HCSG) (Q3 2026) Earnings Call Highlights: Record Revenue

Healthcare Services Group Inc (HCSG) reported Q3 2026 earnings, highlighting record revenue and the NEXDINE acquisition. Challenges include uncertain Genesis bankruptcy recovery ($6.1M estimated), rising SG&A, and unpredictable bad debt. CEO Wahl confirmed low-double-digit 2027 growth outlook, driven by organic momentum and NEXDINE. Q4 revenue guidance includes $150M from NEXDINE. CFO Singh noted SG&A pressure from investments and M&A fees but expects long-term reduction.

$HCSGMed

Healthcare Services Group, Inc. Q3 2026 Earnings Call Summary

Healthcare Services Group (HCSG) reported its ninth straight revenue increase, driven by high retention and new business. The company acquired NEXDINE Hospitality, expanding its senior living and hospitality services. HCSG secured a $6.1 million recovery from Genesis restructuring and raised its 2027 revenue growth outlook to low double digits. Q4 2026 revenue is projected between $535M and $545M, including NEXDINE's $150M contribution. The company also repurchased $11.7M in shares during Q3.

$HCSGMed

HCSG Q3 2026 Earnings Call Transcript

HCSG reported Q3 2026 revenue of $479.6M, with segments Environmental Services at $217.2M (13.3% margin) and Dietary Services at $262.4M (8.7% margin). Q4 2026 revenue is expected to be $535M-$545M, with 2027 revenue growth outlook raised to low double digits. The company reported $24.9M net income ($0.36 EPS) and $30.2M cash flow from operations. HCSG also announced a $6.1M recovery from Genesis restructuring, with potential for higher recovery.

$HCSGMed

What Healthcare Services Group (HCSG) Said on Its Q3 Earnings Call

Healthcare Services Group (HCSG) reported a $3.6M bad-debt benefit in Q3, with adjusted bad-debt expense at $2.5M. CFO Vikas Singh noted SG&A expenses at $48.5M, within target range. The company acquired NEXDINE, expecting $150M annual revenue. Genesis restructuring yielded a $6.1M recovery. HCSG anticipates low-double-digit revenue growth in 2027, with strong cash flow and share repurchases.